|
1
|
Clarke R, Daly L, Robinson K, Naughten E,
Cahalane S, Fowler B and Graham I: Hyperhomocysteinemia: An
independent risk factor for vascular disease. N Engl J Med.
324:1149–1155. 1991.PubMed/NCBI View Article : Google Scholar
|
|
2
|
McCully KS: Vascular pathology of
homocysteinemia: Implications for the pathogenesis of
arteriosclerosis. Am J Pathol. 56:111–128. 1969.PubMed/NCBI
|
|
3
|
Frosst P, Blom HJ, Milos R, Goyette P,
Sheppard CA, Matthews RG, Boers GJ, Den Heijer M, Kluijtmans LA,
Van den Heuvel LP, et al: A candidate genetic risk factor for
vascular disease: A common mutation in methylenetetrahydrofolate
reductase. Nature Genet. 10:111–113. 1995.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sharma P, Senthilkumar RD, Brahmachari V,
Sundaramoorthy E, Mahajan A, Sharma A and Sengupta S: Mining
literature for a comprehensive pathway analysis: A case study for
retrieval of homocysteine related genes for genetic and epigenetic
studies. Lipids Health Dis. 5(1)2006.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Rudreshkumar KJ, Majumdar V, Nagaraja D
and Christopher R: Relevance of plasma levels of free homocysteine
and methionine as risk predictors for ischemic stroke in the young.
Clin Nutr. 37:1715–1721. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Chan MY, Andreotti F and Becker RC:
Hypercoagulable states in cardiovascular disease. Circulation.
118:2286–2297. 2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Rossini R, Capodanno D, Lettieri C,
Musumeci G, Limbruno U, Molfese M, Spatari V, Calabria P, Romano M,
Tarantini G, et al: Long-term outcomes of patients with acute
coronary syndrome and nonobstructive coronary artery disease. Am J
Cardiol. 112:150–155. 2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Akyürek Ö, Akbal E and Güneş F: Increase
in the risk of ST elevation myocardial infarction is associated
with homocysteine level. Arch Med Res. 45:501–506. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ma Y, Peng D, Liu C, Huang C and Luo J:
Serum high concentrations of homocysteine and low levels of folic
acid and vitamin B12 are significantly correlated with
the categories of coronary artery diseases. BMC Cardiovasc Disord.
17(37)2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Anand SS, Yusuf S, Vuksan V, Devanesen S,
Teo KK, Montague PA, Kelemen L, Yi C, Lonn E, Gerstein H, et al:
Differences in risk factors, atherosclerosis, and cardiovascular
disease between ethnic groups in Canada: The study of health
assessment and risk in ethnic groups (SHARE). Lancet. 356:279–284.
2000.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ramesh N and Ganesan K: A study on serum
homocysteine as an independent risk factor for coronary artery
disease. IAIM. 6:75–80. 2019.
|
|
12
|
Bautista LE, Arenas IA, Penuela A and
Martinez LX: Total plasma homocysteine level and risk of
cardiovascular disease: A meta-analysis of prospective cohort
studies. J Clin Epidemiol. 55:882–887. 2002.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chen CY, Yang TC, Chang C, Lu SC and Chang
PY: Homocysteine is a bystander for ST-segment elevation myocardial
infarction: A case-control study. BMC Cardiovasc Disord.
18(33)2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Deepa R, Velmurugan K, Saravanan G,
Karkuzhali K, Dwarakanath V and Mohan V: Absence of association
between serum homocysteine levels and coronary artery disease in
South Indian males. Indian Heart J. 53:44–47. 2001.PubMed/NCBI
|
|
15
|
Brattström L, Wilcken DE, Ohrvik J and
Brudin L: Common methylenetetrahydrofolate reductase gene mutation
leads to hyperhomocysteinemia but not to vascular disease: The
result of a meta-analysis. Circulation. 98:2520–2526.
1998.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bergheanu SC, Bodde MC and Jukema JW:
Pathophysiology and treatment of atherosclerosis: Current view and
future perspective on lipoprotein modification treatment. Neth
Heart J. 25:231–242. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Brattström L and Wilcken DE: Homocysteine
and cardiovascular disease: Cause or effect? Am J Clin Nutr.
72:315–323. 2000.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Arnadottir M, Hultberg B, Nilsson-Ehle P
and Thysell H: The effect of reduced glomerular filtration rate on
plasma total homocysteine concentration. Scand J Clin Lab Invest.
56:41–46. 1996.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Guttormsen AB, Ueland PM, Svarstad E and
Refsum H: Kinetic basis of hyperhomocysteinemia in patients with
chronic renal failure. Kidney Int. 52:495–502. 1997.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Stabler SP, Marcell PD, Podell ER, Allen
RH, Savage DG and Lindenbaum J: Elevation of total homocysteine in
the serum of patients with cobalamin or folate deficiency detected
by capillary gas chromatography-mass spectrometry. J Clin Invest.
81:466–474. 1988.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Verhoef P, Rimm EB, Hunter DJ, Chen J,
Willett WC, Kelsey K and Stampfer MJ: A common mutation in the
methylenetetrahydrofolate reductase gene and risk of coronary heart
disease: Results among U.S. men. J Am Coll Cardiol. 32:353–359.
1998.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tsai MY, Welge BG, Hanson NQ, Bignell MK,
Vessey J, Schwichtenberg K, Yang F, Bullemer FE, Rasmussen R and
Graham KJ: Genetic causes of mild hyperhomocysteinemia in patients
with premature occlusive coronary artery diseases. Atherosclerosis.
143:163–170. 1999.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Folsom AR, Nieto FJ, McGovern PG, Tsai MY,
Malinow MR, Eckfeldt JH, Hess DL and Davis CE: Prospective study of
coronary heart disease incidence in relation to fasting total
homocysteine, related genetic polymorphisms, and B vitamins: The
atherosclerosis risk in communities (ARIC) study. Circulation.
98:204–210. 1998.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kanani PM, Sinkey CA, Browning RL, Allaman
M, Knapp HR and Haynes WG: Role of oxidant stress in endothelial
dysfunction produced by experimental hyperhomocyst(e)inemia in
humans. Circulation. 100:1161–1168. 1999.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Celermajer DS, Sorensen K, Ryalls M,
Robinson J, Thomas O, Leonard JV and Deanfield JE: Impaired
endothelial function occurs in the systemic arteries of children
with homozygous homocystinuria but not in their heterozygous
parents. J Am Coll Cardiol. 22:854–858. 1993.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Bellamy MF, McDowell IF, Ramsey MW,
Brownlee M, Newcombe RG and Lewis MJ: Oral folate enhances
endothelial function in hyperhomocysteinaemic subjects. Eur J Clin
Invest. 29:659–662. 1999.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Schächinger V, Britten MB, Elsner M,
Walter DH, Scharrer I and Zeiher AM: A positive family history of
premature coronary artery disease is associated with impaired
endothelium-dependent coronary blood flow regulation. Circulation.
100:1502–1508. 1999.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Potter K, Hankey GJ, Green DJ, Eikelboom
JW and Arnolda LF: Homocysteine or renal impairment: Which is the
real cardiovascular risk factor? Arterioscler Thromb Vasc Biol.
28:1158–1164. 2008.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wilcken DE and Wilcken B: The natural
history of vascular disease in homocystinuria and the effects of
treatment. J Inherit Metab Dis. 20:295–300. 1997.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Durga J, Bots ML, Schouten EG, Kok FJ and
Verhoef P: Low concentrations of folate, not hyperhomocysteinemia,
are associated with carotid intima-media thickness.
Atherosclerosis. 179:285–292. 2005.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Brown KS, Huang Y, Lu ZY, Jian W, Blair IA
and Whitehead AS: Mild folate deficiency induces a
proatherosclerotic phenotype in endothelial cells. Atherosclerosis.
189:133–141. 2006.PubMed/NCBI View Article : Google Scholar
|
